Citigroup
PACB icon

Citigroup’s Pacific Biosciences PACB Stock Holding History

Citigroup’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-100,000
Closed -$910K – 6544
2022
Q1 		$910K Buy
+100,000
New +$1.15M ﹤0.01% 3061
2020
Q1 		– Sell
-400
Closed -$2K – 7731
2019
Q4 		$2K Sell
400
-900
-69% -$4.58K ﹤0.01% 7556
2019
Q3 		$7K Buy
1,300
+300
+30% +$1.68K ﹤0.01% 7219
2019
Q2 		$6K Sell
1,000
-4,300
-81% -$30.2K ﹤0.01% 7446
2019
Q1 		$38K Sell
5,300
-4,400
-45% -$31.8K ﹤0.01% 6561
2018
Q4 		$72K Sell
9,700
-3,800
-28% -$24.1K ﹤0.01% 5937
2018
Q3 		$73K Buy
13,500
+2,300
+21% +$9.87K ﹤0.01% 6201
2018
Q2 		$40K Buy
11,200
+1,700
+18% +$4.72K ﹤0.01% 6455
2018
Q1 		$19K Sell
9,500
-400
-4% -$1.04K ﹤0.01% 6769
2017
Q4 		$26K Buy
9,900
+9,400
+1,880% +$32.9K ﹤0.01% 6593
2017
Q3 		$3K Sell
500
-600
-55% -$2.58K ﹤0.01% 6959
2017
Q2 		$4K Buy
1,100
+500
+83% +$2.02K ﹤0.01% 6816
2017
Q1 		$3K Buy
600
+400
+200% +$1.96K ﹤0.01% 6932
2016
Q4 		$1K Sell
200
-4,800
-96% -$34.9K ﹤0.01% 7119
2016
Q3 		$45K Sell
5,000
-3,000
-38% -$25.1K ﹤0.01% 5731
2016
Q2 		$56K Buy
+8,000
New +$73.1K ﹤0.01% 5499

Other funds holding PACB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Citigroup's PACB Position: Q2 2026 in Review

Citigroup increased its Pacific Biosciences (PACB) stake by 321% in Q2 2026, buying an estimated $155K and bringing the position to 139,424 shares worth $234K. The position accounts for ﹤0.01% of the portfolio, ranked #4260.

Citigroup first reported a position in PACB in Q2 2013 and has held it in 53 quarters since. The position peaked at $16.3M in Q1 2019. 223 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

  • Citigroup held 139,424 shares of Pacific Biosciences worth $234K as of Q2 2026.
  • Citigroup bought 106,325 Pacific Biosciences shares in Q2 2026, an estimated $155K.
  • Pacific Biosciences made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #4260 holding.
  • Citigroup first reported a position in Pacific Biosciences in Q2 2013 and has held it in 53 quarters since.
  • Citigroup's Pacific Biosciences position peaked at $16.3M in Q1 2019.
  • 223 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.